Tianli Pei

428 total citations
11 papers, 337 citations indexed

About

Tianli Pei is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Tianli Pei has authored 11 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Tianli Pei's work include Ubiquitin and proteasome pathways (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Bioinformatics and Genomic Networks (2 papers). Tianli Pei is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Bioinformatics and Genomic Networks (2 papers). Tianli Pei collaborates with scholars based in China, Canada and United States. Tianli Pei's co-authors include Chao Huang, Chunli Zheng, Xuetong Chen, Yingxue Fu, Yonghua Wang, Jianling Liu, Zihu Guo, Yonghua Wang, Dong Wang and Zongsuo Liang and has published in prestigious journals such as Scientific Reports, Journal of Investigative Dermatology and Journal of Ethnopharmacology.

In The Last Decade

Tianli Pei

11 papers receiving 327 citations

Peers

Tianli Pei
Heying Cui United States
Won-Yung Lee South Korea
Yuanfeng Lyu Hong Kong
Sui‐Lin Mo Australia
Ah‐Won Kwak South Korea
Heying Cui United States
Tianli Pei
Citations per year, relative to Tianli Pei Tianli Pei (= 1×) peers Heying Cui

Countries citing papers authored by Tianli Pei

Since Specialization
Citations

This map shows the geographic impact of Tianli Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianli Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianli Pei more than expected).

Fields of papers citing papers by Tianli Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianli Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianli Pei. The network helps show where Tianli Pei may publish in the future.

Co-authorship network of co-authors of Tianli Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Tianli Pei. A scholar is included among the top collaborators of Tianli Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianli Pei. Tianli Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Pei, Tianli, Yifei Dai, Shengrong Li, et al.. (2023). Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS2 technology. Journal of Ethnopharmacology. 306. 116134–116134. 9 indexed citations
2.
Ma, Xiaofang, Yifei Dai, Xiankuo Yu, et al.. (2023). A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3. Phytomedicine. 120. 155031–155031. 18 indexed citations
3.
Gui, Yu, Yifei Dai, Yumei Wang, et al.. (2022). Taohong Siwu Decoction exerts anticancer effects on breast cancer via regulating MYC, BIRC5, EGF and PIK3R1 revealed by HTS2 technology. Computational and Structural Biotechnology Journal. 20. 3461–3472. 9 indexed citations
4.
Yang, Ruijie, Tianli Pei, Yue Xiao, et al.. (2022). Platycodon grandiflorum Triggers Antitumor Immunity by Restricting PD-1 Expression of CD8+ T Cells in Local Tumor Microenvironment. Frontiers in Pharmacology. 13. 774440–774440. 18 indexed citations
5.
Dai, Yifei, Weijie Qiang, Yu Gui, et al.. (2021). A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional Chinese medicines. Science Bulletin. 66(9). 884–888. 34 indexed citations
6.
Guo, Weinan, Jinyuan Ma, Tianli Pei, et al.. (2018). Up‐regulated deubiquitinase USP4 plays an oncogenic role in melanoma. Journal of Cellular and Molecular Medicine. 22(5). 2944–2954. 31 indexed citations
7.
Guo, Weinan, et al.. (2018). 1195 Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma. Journal of Investigative Dermatology. 138(5). S203–S203. 5 indexed citations
8.
Liu, Jianling, Tianli Pei, Chunli Zheng, et al.. (2016). Systems Pharmacology Uncovers the Multiple Mechanisms of Xijiao Dihuang Decoction for the Treatment of Viral Hemorrhagic Fever. Evidence-based Complementary and Alternative Medicine. 2016(1). 9025036–9025036. 41 indexed citations
9.
Pei, Tianli, Chunli Zheng, Chao Huang, et al.. (2016). Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula. Journal of Ethnopharmacology. 190. 272–287. 77 indexed citations
10.
Zheng, Chunli, Tianli Pei, Chao Huang, et al.. (2016). A novel systems pharmacology platform to dissect action mechanisms of traditional Chinese medicines for bovine viral diarrhea disease. European Journal of Pharmaceutical Sciences. 94. 33–45. 49 indexed citations
11.
Tao, Weiyang, Bohui Li, Shuo Gao, et al.. (2015). CancerHSP: anticancer herbs database of systems pharmacology. Scientific Reports. 5(1). 11481–11481. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026